798
Views
5
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Sorafenib induces partial response in metastatic medullary thyroid carcinoma

, , &
Pages 105-107 | Received 09 Jun 2009, Accepted 25 Jun 2009, Published online: 26 Jan 2010

Figures & data

Figure 1. PET scans (left panel) show a pronounced decrease of metabolic activity of metastatic nodules within the patient's bones, lungs and liver. Right panels reveal a dramatic decrease in the size and number of metastatic nodules in the lungs, mediastinum, thoracolumbar vertebral column, periaortic lymph nodes, left axilla, liver and sternum.

Figure 1. PET scans (left panel) show a pronounced decrease of metabolic activity of metastatic nodules within the patient's bones, lungs and liver. Right panels reveal a dramatic decrease in the size and number of metastatic nodules in the lungs, mediastinum, thoracolumbar vertebral column, periaortic lymph nodes, left axilla, liver and sternum.

Figure 2. Medullary thyroid carcinoma metastatic to the skin and subcutaneous soft tissues of the chest (March 2009). Notice the bands of amyloid (thick arrow) interspersed between nests of tumor cells. An occasional mitotic figure is seen (thin arrow). Hematoxylin and eosin, original magnification ×400.

Figure 2. Medullary thyroid carcinoma metastatic to the skin and subcutaneous soft tissues of the chest (March 2009). Notice the bands of amyloid (thick arrow) interspersed between nests of tumor cells. An occasional mitotic figure is seen (thin arrow). Hematoxylin and eosin, original magnification ×400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.